The epidemiology, pathology and pathogenesis of MS: Therapeutic implications.

Neurotherapeutics · 2025 · PMC12418443 · PMID 40021419

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp < 10 − 16actually significant

This difference between MS patients and non-MS controls is highly significant ( p < 10 − 16 ) .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.